Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...

Hims & Hers Health Inc. shares surged as much as 18% and are on track to close at fresh record after Hunterbrook Media said ...

Hims & Hers shares have gyrated this year after the company started offering copycat versions of GLP-1 injections that are ...

Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...

After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.

Mr. Trump nominated Marty Makary, MD, on Nov. 22 to head the FDA ... Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg ...

Front-month gold futures fell Monday in the largest one-day decline by dollar amount since November 2020, as news of a ...

Traders and investors watched Wall Street's major averages finish Monday on a positive note where the blue-chip Dow outshined ...

President-elect Trump announced on Friday that he is nominating Dr. Marty Makary, a Johns Hopkins School of Medicine ...

The nominee, a surgeon at Johns Hopkins, has criticized the use of pesticides on food and the industry turning against ...

President-elect Trump on Friday announced he is nominating Johns Hopkins School of Medicine professor Dr. Marty Makary for Food and Drug Administration (FDA) commissioner. "I am very pleased to ...

STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President ...